Main Facts: A Quarter-Century of Impact in Cancer Surveillance Lori Swain, MS, stands as one of the...
Patient Advocacy and Support
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged...
In the rapidly shifting landscape of modern oncology, the transition from traditional, generalized treatment protocols to highly...
The serene landscape of Arizona in 2024 was meant to be a sanctuary for Alyssa Butts—a place...
TORONTO — As the medical community and patient advocates observe Breast Cancer Awareness Month, Breast Cancer Canada...
NEW YORK – In the heart of Manhattan, where the relentless pace of commuter life usually dictates...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) medications have surged into...
OTTAWA – A landmark national survey released by Breast Cancer Canada (BCC) has uncovered a profound consensus...
Advocacy as a Lifeline: How METAvivor is Reshaping the Policy Landscape for Metastatic Breast Cancer
Advocacy as a Lifeline: How METAvivor is Reshaping the Policy Landscape for Metastatic Breast Cancer
In the complex ecosystem of medical research and healthcare policy, the voices of those living with terminal...
NEW YORK CITY — In the grand, echoing expanse of Grand Central Terminal’s Vanderbilt Hall, a different...
